AR and prostate carcinoma: The action of androgens is mediated via the androgen receptor (AR), a ligand-activated transcription factor and member of the steroid hormone nuclear receptor family, which mediates androgen signaling by binding to androgen response elements (AREs) in both normal prostate tissue and prostate cancer [20,21,22].